Pectolinarin

CAS No. 28978-02-1

Pectolinarin( —— )

Catalog No. M17467 CAS No. 28978-02-1

Pectolinarin is a Cirsium isolate with anti-inflammatory activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 58 In Stock
25MG 105 In Stock
50MG 169 In Stock
100MG 255 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pectolinarin
  • Note
    Research use only, not for human use.
  • Brief Description
    Pectolinarin is a Cirsium isolate with anti-inflammatory activity.
  • Description
    Pectolinarin is a Cirsium isolate with anti-inflammatory activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    Others
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    28978-02-1
  • Formula Weight
    622.59
  • Molecular Formula
    C29H34O15
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 31.25 mg/mL (50.20 mM)
  • SMILES
    C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)Oc1c(c(c2c(c1)oc(cc2=O)c1ccc(cc1)OC)O)OC)O)O)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yoo YM, et al. Biol Pharm Bull. 2008 Apr;31(4):760-4.
molnova catalog
related products
  • Org-12962

    Org-12962 is an effective and selective 5-HT2C receptor agonist pEC50: 7.01). Org-12962 shows antiaversive effects in a rat model of panic-like anxiety.

  • CTEP

    CTEP (RO4956371) is a novel, long-acting, orally bioavailable allosteric antagonist of mGlu5 receptor with IC50 of 2.2 nM, shows >1000-fold selectivity over other mGlu receptors.

  • Pergolide mesylate s...

    PERGOLIDE MESYLATE is a long-acting dopamine agonist which has been used to treat parkinson disease and hyperprolactinemiabut withdrawn from some markets due to potential for heart valve diseases.